Cargando…
Quantitative proteomic analysis of mitochondria from human ovarian cancer cells and their paclitaxel-resistant sublines
Paclitaxel resistance is a major obstacle for the treatment of ovarian cancer. The chemoresistance mechanisms are partly related to the mitochondria. Identification of the relevant proteins in mitochondria will help in clarifying the possible mechanisms and in selecting effective chemotherapy for pa...
Autores principales: | Chen, Ming, Huang, Hong, He, Haojie, Ying, Wantao, Liu, Xin, Dai, Zhiqin, Yin, Jie, Mao, Ning, Qian, Xiaohong, Pan, Lingya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556398/ https://www.ncbi.nlm.nih.gov/pubmed/26033570 http://dx.doi.org/10.1111/cas.12710 |
Ejemplares similares
-
Secretion of annexin A3 from ovarian cancer cells and its association with platinum resistance in ovarian cancer patients
por: Yin, Jie, et al.
Publicado: (2012) -
Quantitative proteomics reveal the anti-tumour mechanism of the carbohydrate recognition domain of Galectin-3 in Hepatocellular carcinoma
por: Wang, Mingchao, et al.
Publicado: (2017) -
Quantitative Proteomics Analysis Identifies Mitochondria as Therapeutic Targets of Multidrug-Resistance in Ovarian Cancer
por: Chen, Xiulan, et al.
Publicado: (2014) -
Cell-cycle synchronization reverses Taxol resistance of human ovarian cancer cell lines
por: Wang, Xueqing, et al.
Publicado: (2013) -
Mitochondria P-glycoprotein confers paclitaxel resistance on ovarian cancer cells
por: Guo, Weina, et al.
Publicado: (2019)